Treatment of Benign Prostatic Hyperplasia
| Autor: | Luís Campos Pinheiro, João Martins Pisco |
|---|---|
| Rok vydání: | 2012 |
| Předmět: |
Male
medicine.medical_specialty Invasive treatments business.industry medicine.medical_treatment Prostatic Hyperplasia Transurethral Resection of Prostate Urology Hyperplasia urologic and male genital diseases medicine.disease Prostatic enlargement 5-alpha Reductase Inhibitors Treatment Outcome Lower urinary tract symptoms medicine Humans Minimally Invasive Surgical Procedures Radiology Nuclear Medicine and imaging Laser Therapy Prostatic obstruction Cardiology and Cardiovascular Medicine business Adrenergic alpha-Antagonists Transurethral resection of the prostate |
| Zdroj: | Techniques in Vascular and Interventional Radiology. 15:256-260 |
| ISSN: | 1089-2516 |
| Popis: | Lower urinary tract symptoms (LUTS) may be a sign of aging rather than a consequence of benign prostatic enlargement (BPE) or benign prostatic obstruction (BPO). Medical or invasive treatments should address the bothersome symptoms and the quality of life of patients. Alpha blockers and 5-alpha reductase inhibitors are most frequently used in benign prostatic hyperplasia (BPH) medical treatments, whereas Transurethral Resection of the Prostate (TURP) remains the "gold standard" for surgical treatments. Several minimal invasive treatments are emerging with promising outcomes. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect